Key Takeaways
- • Meiji Yasuda Life Insurance has agreed to commit up to 200 billion yen (approximately $1.25 billion) to an expanded partnership with Man Group Plc, focused on private credit.
- • The arrangement includes the potential acquisition by Meiji Yasuda of a 5% stake in Man Group, described as the world's largest publicly traded hedge fund group.
- • The two firms will co-develop products, and Man Group will become a preferred asset management partner for the Japanese insurer, according to a statement issued Monday.
Summary
Meiji Yasuda Life Insurance Co. has agreed an expanded partnership with London-based Man Group Plc, under which the Japanese insurer will commit up to 200 billion yen ($1.25 billion) to private credit strategies and may acquire a 5% stake in the hedge fund manager, according to Bloomberg.
Under the arrangement, the two companies will co-develop investment products. Man Group will also become a preferred asset management partner for Meiji Yasuda, positioning the alternative asset manager as a core external manager for one of Japan's largest life insurers.
The announcement was made in a statement issued on Monday. The primary source does not provide further detail on timing of the stake acquisition, the allocation split across private credit vehicles, or regulatory approvals required, so those terms should be considered pending.
For institutional allocators, the deal underscores continued demand from Asian insurers for private credit exposure and the growing role of large alternative managers in distributing and co-developing products for long-duration capital.
Under the arrangement, the two companies will co-develop investment products. Man Group will also become a preferred asset management partner for Meiji Yasuda, positioning the alternative asset manager as a core external manager for one of Japan's largest life insurers.
The announcement was made in a statement issued on Monday. The primary source does not provide further detail on timing of the stake acquisition, the allocation split across private credit vehicles, or regulatory approvals required, so those terms should be considered pending.
For institutional allocators, the deal underscores continued demand from Asian insurers for private credit exposure and the growing role of large alternative managers in distributing and co-developing products for long-duration capital.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.